China Thickening Agent for Pharmaceuticals - Hatorite WE
Product Main Parameters
| Parameter | Value |
|---|---|
| Appearance | Free flowing white powder |
| Bulk Density | 1200~1400 kg·m-3 |
| Particle size | 95%＜250μm |
| Loss on Ignition | 9~11% |
| pH（2% suspension） | 9~11 |
| Conductivity（2% suspension） | ≤1300 |
| Clarity（2% suspension） | ≤3min |
| Viscosity（5% suspension） | ≥30,000 cPs |
| Gel strength（5% suspension） | ≥ 20g·min |
Common Product Specifications
| Application | Usage |
|---|---|
| Coatings | 0.2-2% of total formulation volume |
| Cosmetics | 0.2-2% of total formulation volume |
| Detergent | 0.2-2% of total formulation volume |
| Adhesive | 0.2-2% of total formulation volume |
| Ceramic Glazes | 0.2-2% of total formulation volume |
| Building Materials | 0.2-2% of total formulation volume |
| Agrochemical | 0.2-2% of total formulation volume |
| Oilfield | 0.2-2% of total formulation volume |
| Horticultural Products | 0.2-2% of total formulation volume |
Product Manufacturing Process
Synthetic layered silicates are produced through a meticulous process involving the combination of silicate materials with specific chemical treatments. According to authoritative sources in materials science, this involves the use of controlled hydrothermal synthesis or sol-gel processes. The production process is critical to obtaining a uniform structure, thus ensuring its effective use as a thickening agent in pharmaceuticals, especially in waterborne systems.
The conclusion drawn from several authoritative papers indicates that maintaining the precise temperature, pH, and reaction time is essential for achieving high-quality Hatorite WE with optimal thickening properties. This synthetic process allows for the tailoring of specific rheological characteristics, making it an excellent choice for a wide range of pharmaceutical formulations.
Product Application Scenarios
Hatorite WE is extensively utilized in pharmaceutical formulations where precise viscosity control is critical. According to studies published in leading pharmaceutical journals, its application spans topical, oral, and ophthalmic preparations. For topical applications, it is praised for its ability to enhance spreadability and provide controlled release of active ingredients. In oral formulations, it stabilizes suspensions and emulsions by preventing the separation of phases, thus ensuring even distribution of active ingredients. Additionally, in ophthalmic applications, Hatorite WE increases the retention time of formulations on the eye surface, enhancing bioavailability and therapeutic efficacy.
The consistent findings from authoritative sources underscore the versatility of Hatorite WE as a reliable thickening agent, particularly in waterborne pharmaceutical systems.
Product After-Sales Service
We offer comprehensive after-sales service for Hatorite WE. Our technical support team is available to assist with product application inquiries and troubleshooting. We also provide ongoing consultation to ensure optimal usage and performance in your specific formulations.
Product Transportation
Hatorite WE is packaged securely in 25 kg HDPE bags or cartons, palletized and shrink-wrapped for safe transportation. We ensure compliance with international shipping standards to maintain product integrity during transit.
Product Advantages
- Exceptional rheological properties
- Wide pH and temperature stability range
- Eco-friendly and cruelty-free production
- Proven efficacy in diverse pharmaceutical applications
Product FAQ
- What is the primary benefit of using Hatorite WE in formulations?
Hatorite WE provides exceptional thixotropic properties, enhancing stability and viscosity across a variety of pharmaceutical systems, particularly in waterborne formulations.
- How does Hatorite WE promote sustainable pharmaceutical practices?
Produced under eco-friendly conditions, Hatorite WE is part of Jiangsu Hemings' commitment to green and low-carbon transformation, aligning with sustainable pharmaceutical manufacturing.
- Is Hatorite WE suitable for all pH ranges?
Hatorite WE is effective within a pH range of 6 to 11, suitable for most pharmaceutical applications, ensuring stability and performance across different formulations.
- Can Hatorite WE be used in high-temperature environments?
Yes, Hatorite WE maintains its rheological properties over a broad temperature range, making it suitable for formulations exposed to varying temperatures.
- What are the packaging options for Hatorite WE?
Our product is packed in 25 kg HDPE bags or cartons, palletized and shrink-wrapped, ensuring safe storage and transportation.
- How should Hatorite WE be stored for optimal performance?
To preserve its quality, Hatorite WE should be stored in a dry environment, protected from moisture to prevent degradation of its thixotropic properties.
- Are there specific mixing requirements for Hatorite WE?
For best results, prepare a pre-gel with 2% solid content using high shear dispersion methods before adding to formulations.
- What is the typical usage level of Hatorite WE in formulations?
Hatorite WE typically constitutes 0.2-2% of the total formulation mass, but optimal usage should be determined through testing.
- What are the main applications of Hatorite WE?
Hatorite WE is versatile, used in coatings, cosmetics, adhesives, and pharmaceuticals, excelling as a thickener and anti-settling agent.
- Is technical support available for users of Hatorite WE?
Yes, our expert team is available to assist with any technical queries, ensuring you achieve the best outcomes in your product formulations.
Product Hot Topics
- The Rise of Synthetic Clay in Pharmaceutical Formulations
Synthetic clays like Hatorite WE are gaining prominence in pharmaceutical formulations, thanks to their superior thixotropic properties and ability to enhance product stability. In China, the use of such thickening agents in pharmaceuticals is skyrocketing as manufacturers seek to innovate and improve product efficacy. The versatility of these agents ensures they meet the diverse needs of the industry, from topical applications to complex emulsions. As the demand for more sustainable and efficient pharmaceutical products grows, synthetic clay products are at the forefront of this transformation.
- Why China is Leading in Pharmaceutical Thickening Agents
China is fast becoming a leader in the pharmaceutical thickening agent market, with products like Hatorite WE exemplifying this growth. The country's focus on R&D and sustainable practices positions it uniquely in the industry. With a strong commitment to eco-friendly production and consistent quality, Chinese manufacturers are setting global standards. The ability to innovate and adapt to market demands further cements China's role at the forefront of pharmaceutical advancements, particularly in thickening agents.
Image Description
